Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade
Kobe Yuen, Lifen Liu, Vinita Gupta, et al.
Nature Medicine (2020) Vol. 26, Iss. 5, pp. 693-698
Open Access | Times Cited: 347

Showing 1-25 of 347 citing articles:

Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia, Emilio Sanseviero, Dmitry I. Gabrilovich
Nature reviews. Immunology (2021) Vol. 21, Iss. 8, pp. 485-498
Open Access | Times Cited: 1239
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 866
TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment
Dongqing Sun, Jin Wang, Ya Han, et al.
Nucleic Acids Research (2020) Vol. 49, Iss. D1, pp. D1420-D1430
Open Access | Times Cited: 781
Interleukins in cancer: from biology to therapy
Daria Briukhovetska, Janina Dörr, Stefan Endres, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 481-499
Open Access | Times Cited: 542
Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 522
Exploiting senescence for the treatment of cancer
Liqin Wang, Lina Lankhorst, René Bernards
Nature reviews. Cancer (2022) Vol. 22, Iss. 6, pp. 340-355
Open Access | Times Cited: 511
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 468
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
Rilan Bai, Zheng Lv, Dongsheng Xu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 386
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
Terence K. Lee, Xin‐Yuan Guan, Stephanie Ma
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 26-44
Closed Access | Times Cited: 317
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial
Vivek Narayan, Julie S. Barber-Rotenberg, In-Young Jung, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 724-734
Open Access | Times Cited: 302
Interleukin-8: An evolving chemokine
Kouji Matsushima, De Yang, Joost J. Oppenheim
Cytokine (2022) Vol. 153, pp. 155828-155828
Open Access | Times Cited: 273
Beyond conventional immune-checkpoint inhibition — novel immunotherapies for renal cell carcinoma
David A. Braun, Ziad Bakouny, Laure Hirsch, et al.
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 199-214
Open Access | Times Cited: 256
Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment
Xianwen Ren, Lei Zhang, Yuanyuan Zhang, et al.
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 583-609
Closed Access | Times Cited: 245
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
Chang Yang, Bairong Xia, Zhao-Cong Zhang, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 240
An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancer
Paula Voabil, Marjolein de Bruijn, Lisanne M. Roelofsen, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1250-1261
Closed Access | Times Cited: 239
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention
Seppe Cambier, Mieke Gouwy, Paul Proost
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 3, pp. 217-251
Open Access | Times Cited: 232
Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression
Kristen Fousek, Lucas A. Horn, Claudia Palena
Pharmacology & Therapeutics (2020) Vol. 219, pp. 107692-107692
Open Access | Times Cited: 225
Neutrophil phenotypes and functions in cancer: A consensus statement
Daniela F. Quail, Borko Amulic, Monowar Aziz, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 6
Open Access | Times Cited: 207
Antitumour immunity regulated by aberrant ERBB family signalling
Shogo Kumagai, Shohei Koyama, Hiroyoshi Nishikawa
Nature reviews. Cancer (2021) Vol. 21, Iss. 3, pp. 181-197
Closed Access | Times Cited: 202
CXCR4 inhibition in human pancreatic and colorectal cancers induces an integrated immune response
Daniele Biasci, Martin Smoragiewicz, Claire M. Connell, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 46, pp. 28960-28970
Open Access | Times Cited: 199
IL8, Neutrophils, and NETs in a Collusion against Cancer Immunity and Immunotherapy
Álvaro Teijeira, Saray Garasa, María C. Ochoa, et al.
Clinical Cancer Research (2020) Vol. 27, Iss. 9, pp. 2383-2393
Open Access | Times Cited: 177
B cell-specific XIST complex enforces X-inactivation and restrains atypical B cells
Bingfei Yu, Yanyan Qi, Rui Li, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1790-1803.e17
Open Access | Times Cited: 163
The cutting-edge progress of immune-checkpoint blockade in lung cancer
Fei Zhou, Meng Qiao, Caicun Zhou
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 2, pp. 279-293
Open Access | Times Cited: 155
How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer
Jacob Stultz, Lawrence Fong
Prostate Cancer and Prostatic Diseases (2021) Vol. 24, Iss. 3, pp. 697-717
Open Access | Times Cited: 149
Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 149
Page 1 - Next Page

Scroll to top